Epstein-Barr virus (EBV) is an oncogenic Human Herpesvirus that infects B lymphocytes. EBV's Latent Membrane Protein-1 (LMP-1) is a constitutively active Tumor Necrosis Factor Receptor analog that activates a myriad of signaling pathways. LMP-1 activates NF-κ B signaling, cytostasis, and suppresses interferon alpha (IFNα) signaling. This thesis characterizes LMP-1 signaling and dissects LMP-1 complex formation in infected cells. Structure function analysis revealed that the first transmembrane domain of LMP-1 is required for suppression of IFNα signaling. The LMP-1 C-terminus, dispensable for suppression of IFNα signaling in B cells, is required for IFNα suppression in 293T cells. These findings indicate that the mechanisms of suppression IFNα signaling in these two cell types are different. LMP-1 signaling activity correlates with its ability to oligomerize and localize in membrane microdomains. A high molecular weight species of LMP-1 was identified by non-reducing SDS-PAGE analysis and shown to be a cysteine 238 disulfide linked homo-dimer. Dimeric LMP-1 co-purifies with TRAF3 and dimeric LMP-1 is restricted to lipid rafts. Ability to crosslink interacting LMP-1 monomers requires the LMP-1 transmembrane domain and correlates with signaling activity. These findings support the model in which complex formation is key for LMP-1 signaling activity. I explored the hypothesis that LMP-1 signals to its various effectors not by forming one large multimeric signaling complex but forming multiple distinct complexes. Analysis of extracts from EBV-infected cells by BN-PAGE demonstrated LMP-1 forms multiple high molecular weight native complexes. The larger subset (>669 kDa) of these complexes is enriched in lipid rafts, as is actively signaling LMP-1. The smaller subset of complexes (<669kDa) is found primarily in detergent soluble membranes, as are nonfunctional LMP-1 variants. Recombinant purified LMP-1 and LMP-1 mutants lacking transmembrane helices are unable to form the highest molecular weight complexes (>669 kDa). These results demonstrate that the intact transmembrane domain of LMP-1 is not only important in IFNα signaling suppression, but plays an essential role in LMP-1 homo-oligomerization and higher order complex formation. Understanding the mechanisms by which LMP-1 activates signaling is necessary for understanding the oncogenicity of LMP-1 and for development of effective therapeutics to disrupt this signaling activity.
|Advisor:||Martin, Jennifer M.|
|Commitee:||Detweiler, Corrella, Odorizzi, Charles, Olwin, Bradley B., Yin, Hubert|
|School:||University of Colorado at Boulder|
|Department:||Molecular, Cellular and Developmental Biology|
|School Location:||United States -- Colorado|
|Source:||DAI-B 72/07, Dissertation Abstracts International|
|Subjects:||Molecular biology, Biochemistry, Virology|
|Keywords:||Epstein-Barr virus, Interferon, Latent membrane protein, Transmembrane domains, Viral signaling|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be